--- a +++ b/clusters/9knumclustersv2/clust_1029.txt @@ -0,0 +1,60 @@ +Evidence of clinically significant cardiovascular and respiratory conditions +Clinically significant cardiovascular disease +Subjects with clinically significant cardiovascular disease, including: +Clinically significant cardiovascular disease +Clinically significant cardiovascular disease or condition +Patients with clinically significant cardiovascular disease, thromboembolic disease, or significant risk of bleeding. +Clinically significant cardiovascular or pulmonary disease +History of clinically significant cardiovascular disease +Clinically significant cardiovascular disease. +Clinically significant cardiovascular disease or condition +History of clinically significant cardiovascular disease; +Clinically significant cardiovascular disease. +Clinically significant cardiovascular disease +Clinically significant cardiovascular disease. +Have clinically significant, uncontrolled, or active cardiovascular disease, specifically including, but not restricted to: +Clinically significant cardiovascular disease +Clinically significant cardiovascular disease including: +Clinically significant cardiovascular disease or condition +Subjects who developed cardiovascular disease within weeks prior to study entry, which is deemed to be clinically significant by the Investigator. +Known clinically significant cardiovascular disease or condition. +Impaired cardiovascular function or clinically significant cardiovascular disease including any of the following: symptomatic congestive heart failure, clinically significant cardiac arrhythmias and/or conduction abnormalities < months prior to screening except for atrial fibrillation and paroxysmal supraventricular tachycardia +Clinically significant, uncontrolled, cardiovascular disease. +History of clinically-significant cardiovascular disease. +Clinically significant cardiovascular disease +Clinically significant cardiovascular risk. +Clinically significant (i.e., active) cardiovascular disease +Clinically significant cardiovascular disease +Subject has clinically significant cardiovascular disease. +Clinically significant cardiovascular disease; +Clinically symptomatic and uncontrolled cardiovascular disease +Patients with clinically significant cardiovascular disease. +Patients with clinically significant, uncontrolled cardiovascular disease +Subjects with clinically significant cardiovascular disease. +Subject has clinically significant cardiovascular disease including: +Subjects with clinically significant cardiovascular disease. This includes: +Clinically significant cardiovascular disease; +Clinically significant cardiovascular disease +Clinically significant cardiovascular disease +Clinically significant (that is, active) cardiovascular disease +Impaired cardiovascular function or clinically significant cardiovascular diseases +Impaired cardiovascular function or clinically significant cardiovascular diseases. +Impaired cardiovascular function or clinically significant cardiovascular diseases +History of clinically significant cardiovascular disease including. +Clinically significant cardiovascular disease; +History of clinically significant cardiovascular disease including: +Clinically significant cardiovascular disease at screening including: +Clinically significant cardiovascular disease. +Clinically significant cardiovascular impairment +Impaired cardiovascular function or clinically significant cardiovascular diseases, including any of the following: symptomatic chronic heart failure; evidence of clinically significant cardiac arrhythmias and/or conduction abnormalities < months prior to screening except atrial fibrillation and paroxysmal supraventricular tachycardia +Clinically significant cardiovascular risk +Clinically significant cardiovascular disease +Clinically significant cardiovascular disease including: +Uncontrolled hypertension or clinically significant cardiovascular disease +Impaired cardiovascular function or clinically significant cardiovascular diseases +History of clinically-significant cardiovascular disease +History of clinically significant cardiovascular disease, gastrointestinal disorder, or significant pulmonary compromise. +History of clinically significant cardiovascular disease +Clinically severe cardiovascular disease or clinically significant electrocardiogram (ECG) abnormality. +Clinically significant cardiac/cardiovascular disease, or pulmonary compromise +Clinically significant cardiovascular disease including: